Cytosar 500 mg Injection
  1. Home
  2. Pharma Products
  3. Pfizer Ltd
  4. Cytosar 500 mg Injection

Cytosar 500 mg Injection

Cytosar 500 mg Injection contains cytarabine, an antineoplastic medicine used in the treatment of certain blood cancers. It interferes with DNA synthesis and helps slow or stop the growth of rapidly dividing cancer cells. The medicine is administered by a healthcare professional according to the prescribed treatment protocol.

BUY NOW

Category

Cytosar 500 mg is supplied as a powder for solution for injection containing 500 mg of cytarabine per vial. Cytarabine is commonly used in chemotherapy regimens for acute leukemias and other selected hematological malignancies. The product must be reconstituted before administration, with the route and dosage determined by the specific treatment regimen. Its use requires specialist supervision because dosing and administration vary substantially according to the disease and chemotherapy protocol.

Technical Specification

Specification Details
Active Ingredient Cytarabine 500 mg
Dosage Form Powder for Solution for Injection
Therapeutic Class Antimetabolite
Main Indication Acute Myeloid Leukemia
Route of Administration Intravenous
Pack Presentation 500 mg per Vial

Product Also Known As

Cytosar 500 mg Injection, Cytosar 500 mg Vial, Cytarabine 500 mg Injection, Cytarabine 500 mg Vial, Cytarabine Oncology Injection, Ara-C Injection